Published in J Magn Reson Imaging on October 01, 2002
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85
Golden-angle radial sparse parallel MRI: combination of compressed sensing, parallel imaging, and golden-angle radial sampling for fast and flexible dynamic volumetric MRI. Magn Reson Med (2013) 1.99
Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology (2006) 1.80
MRI of carotid atherosclerosis: clinical implications and future directions. Nat Rev Cardiol (2010) 1.78
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol (2008) 1.74
Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol (2008) 1.73
Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts. Cancer Biol Ther (2009) 1.63
Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer (2006) 1.54
Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia (2005) 1.45
Functional MRI of the kidney: tools for translational studies of pathophysiology of renal disease. Am J Physiol Renal Physiol (2006) 1.38
Respiratory motion-compensated radial dynamic contrast-enhanced (DCE)-MRI of chest and abdominal lesions. Magn Reson Med (2008) 1.34
Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. Mol Pharm (2010) 1.28
Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements. Eur J Nucl Med Mol Imaging (2010) 1.21
Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer (2014) 1.18
Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia (2008) 1.15
Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev (2009) 1.12
Feasibility of high temporal resolution breast DCE-MRI using compressed sensing theory. Med Phys (2010) 1.10
Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique. J Clin Pathol (2005) 1.08
A grid-based image archival and analysis system. J Am Med Inform Assoc (2005) 1.04
Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging. Methods Enzymol (2012) 1.01
Practical considerations in T1 mapping of prostate for dynamic contrast enhancement pharmacokinetic analyses. Magn Reson Imaging (2012) 0.99
Clinical biomarkers of angiogenesis inhibition. Cancer Metastasis Rev (2008) 0.98
Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis. Magn Reson Med (2009) 0.97
Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI. J Magn Reson (2007) 0.97
UMMPerfusion: an open source software tool towards quantitative MRI perfusion analysis in clinical routine. J Digit Imaging (2013) 0.96
Multiplexed imaging in cancer diagnosis: applications and future advances. Lancet Oncol (2010) 0.92
Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma model. PLoS One (2011) 0.92
Temporal/spatial resolution improvement of in vivo DCE-MRI with compressed sensing-optimized FLASH. Magn Reson Imaging (2012) 0.92
Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice. Pharm Res (2009) 0.91
Functional magnetic resonance: biomarkers of response in breast cancer. Breast Cancer Res (2011) 0.91
Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging. Contrast Media Mol Imaging (2013) 0.91
Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol (2011) 0.91
Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions. Eur Radiol (2007) 0.90
MRI in the early identification and classification of high-risk atherosclerotic carotid plaques. Imaging Med (2010) 0.89
Correlative BOLD MR imaging of stages of synovitis in a rabbit model of antigen-induced arthritis. Pediatr Radiol (2011) 0.89
DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility. J Magn Reson Imaging (2013) 0.88
Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI. AJR Am J Roentgenol (2013) 0.88
Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer. Radiology (2010) 0.87
Dynamic contrast-enhanced magnetic resonance imaging parameters independent of baseline T10 values. Magn Reson Imaging (2009) 0.87
The future of collateral artery research. Curr Cardiol Rev (2014) 0.86
Rapid simultaneous acquisition of T1 and T2 mapping images using multishot double spin-echo EPI and automated variations of TR and TE (ms-DSEPI-T12). NMR Biomed (2010) 0.86
Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101. Clin Cancer Res (2013) 0.85
Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction. Invest Radiol (2015) 0.84
Spatially regularized T(1) estimation from variable flip angles MRI. Med Phys (2012) 0.84
MRI-based prediction of pulsed high-intensity focused ultrasound effect on tissue transport in rabbit muscle. J Magn Reson Imaging (2013) 0.83
Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI. Cancer Res (2013) 0.83
SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries. J Cardiovasc Magn Reson (2013) 0.82
Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. Magn Reson Med (2010) 0.82
Imaging of angiogenesis. Angiogenesis (2010) 0.82
Review of photoacoustic flow imaging: its current state and its promises. Photoacoustics (2015) 0.81
Dynamic MRI and fine needle aspiration cytology in the evaluation of soft tissue lesions. Skeletal Radiol (2003) 0.81
Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study. BMC Cancer (2011) 0.81
Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques. NMR Biomed (2015) 0.79
Can DCEMRI assess the effect of green tea on the angiogenic properties of rodent prostate tumors? Phys Med (2009) 0.79
Contrast-enhanced triggered harmonic sonography for assessment of periarticular hemodynamic changes in experimental arthritis. Pediatr Radiol (2006) 0.78
Physiologic characterization of inflammatory arthritis in a rabbit model with BOLD and DCE MRI at 1.5 Tesla. Eur Radiol (2014) 0.77
Glucosamine sulfate effect on the degenerated patellar cartilage: preliminary findings by pharmacokinetic magnetic resonance modeling. Eur Radiol (2009) 0.77
Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy. J Magn Reson Imaging (2009) 0.77
Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy. Clin Lipidol (2012) 0.77
The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck. PLoS One (2013) 0.77
Functional and molecular imaging with MRI: potential applications in paediatric radiology. Pediatr Radiol (2010) 0.77
Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI. MAGMA (2011) 0.77
Systematic protocol for assessment of the validity of BOLD MRI in a rabbit model of inflammatory arthritis at 1.5 tesla. Pediatr Radiol (2013) 0.76
Magnetic resonance in the detection of breast cancers of different histological types. Magn Reson Insights (2013) 0.76
DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model-initial experience. MAGMA (2015) 0.75
A role for dynamic contrast-enhanced magnetic resonance imaging in predicting tumour radiation response. Br J Cancer (2016) 0.75
Novel nano-sized MR contrast agent mediates strong tumor contrast enhancement in an oncogene-driven breast cancer model. PLoS One (2014) 0.75
Assessment of MRI Contrast Agent Kinetics via Retro-Orbital Injection in Mice: Comparison with Tail Vein Injection. PLoS One (2015) 0.75
Newer imaging techniques in head and neck cancer. Indian J Surg Oncol (2010) 0.75
Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients. Chin J Cancer Res (2015) 0.75
Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI. EJNMMI Res (2016) 0.75
Dynamic Contrast-Enhanced MRI in the Study of Brain Tumors. Comparison Between the Extended Tofts-Kety Model and a Phenomenological Universalities (PUN) Algorithm. J Digit Imaging (2015) 0.75
Quantitative [(18)F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer. Mol Imaging Biol (2016) 0.75
Bridging Sunitinib Exposure to Time-to-Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker. CPT Pharmacometrics Syst Pharmacol (2016) 0.75
Value of Dynamic Contrast-Enhanced MRI to Detect Local Tumor Recurrence in Primary Head and Neck Cancer Patients. Medicine (Baltimore) (2016) 0.75
Endometrial cancer: diagnostic value of quantitative measurements of microvascular changes with DCE-MR imaging. MAGMA (2014) 0.75
Assessment of pharmacokinetics for microvessel proliferation by DCE-MRI for early detection of physeal bone bridge formation in an animal model. MAGMA (2017) 0.75
Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer. Eur Radiol (2016) 0.75
Childhood extracranial neoplasms: the role of imaging in drug development and clinical trials. Pediatr Radiol (2015) 0.75